Immunogenicity and Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in 2-month-old and 3-month-old Healthy Volunteers
A Single-center, Randomised, Blind, Similar Vaccine Control, Non-inferior Designed Phase III Clinical Trial to Evaluate Immunogenicity and Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in 2-month-old and 3-month-old Healthy Volunteers
Sponsor: Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
A PHASE3 clinical study on Pneumonia, Pneumococcal, this trial is actively recruiting participants. The trial is conducted by Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd and has accumulated 4 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Not Yet Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Not Yet Recruiting PHASE3
-
May 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
For direct contact, visit the study record on ClinicalTrials.gov .